RT Journal Article
SR Electronic
T1 CREATION OF SAFE DOSE ZONES USING ISODOSE MAPS IN VIDEO FLUOROSCOPIC SWALLOWING STUDIES FOR PEDIATRIC PATIENTS
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.14.24307144
DO 10.1101/2024.05.14.24307144
A1 María Ignacia Gac, P.
A1 Sofía Moncada, H.
A1 Mathias Redenz, R.
A1 Marco Jiménez, H.
A1 Ricardo Castillo, V.
YR 2024
UL http://medrxiv.org/content/early/2024/05/15/2024.05.14.24307144.abstract
AB Background During video fluoroscopic procedures in pediatric patients, a considerable number of individuals, including occupationally exposed professionals (OEP) and patient companions, must be present, exposing themselves to radiation.Objective To determine safety areas for OEP to receive the lowest absorbed dose during the examination, as shown in isodose maps.Method Technical parameters used in the examination were obtained by reviewing exams conducted during the years 2021 and 2022. Subsequently, a procedure was conducted to simulate these data using an anthropomorphic phantom and taking measurements at different points and levels of the examination room to create a map with dose zones in three dimensions. A Geiger Müller ionization chamber was used to measure the doses.Results It was found that the points closest to the patient at pelvic level of the professional had the highest doses.Conclusion OEP who must remain close to the patient have an essential obligation to comply with the use of radiological protection elements, and the relocation of elements in the room could be considered.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:ethics committee Undergraduate Scientific Alemana Clinical Medicine Faculty Desarrollo University Santiago Chile approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors